Most read article(s)

Commentary
Tackling Quality—It's Never a Level Playing FieldCompanion Piece to the Neurology Outcome Measure Set
Brian Cabaniss, Korwyn Williams, Meghan Ward, et al.

January 20, 2022
Commentary
Cost and Return on Investment of a Team-Based Palliative Care Program for Parkinson Disease
Robert Brett McQueen, Mark Gritz, Drew Kern, et al.

October 26, 2022
Research Article
Humanistic Burden of Huntington Disease: Evidence From the Huntington Disease Burden of Illness Study
Idaira Rodriguez Santana, Samuel Frank, Maria Doherty, et al.

October 12, 2022
Research Article
Online vs Face-to-Face Administration of Impulse Control Disorder Questionnaires in Parkinson DiseaseDoes Method Matter?
Bonnie M. Scott, Robert S. Eisinger, Revath Sankar, et al.

August 31, 2022
Research Article
Uses of the NIH Toolbox® in Clinical SamplesA Scoping Review
Rina S. Fox, Manrui Zhang, Saki Amagai, et al.

July 05, 2022
Research Article
Health Care Utilization in the Last Year of Life in Parkinson Disease and Other Neurodegenerative Movement Disorders
Erica D McKenzie, Veronica Andrea Bruno, Andrew Fong, et al.

October 12, 2022
Research
Using Semiology to Classify Epileptic Seizures vs Psychogenic Nonepileptic SeizuresA Meta-analysis
Subramanian Muthusamy, Udaya Seneviratne, Catherine Ding, et al.

March 29, 2022
Commentary
Confirming a Historical Diagnosis of Multiple SclerosisChallenges and Recommendations
Andrew J. Solomon, Georgina Arrambide, Wallace Brownlee, et al.

January 06, 2022
Clinical/Scientific Note
Area Postrema SyndromeAn Initial Presentation of Double-Seropositive AQP4 and MOG Antibodies
Abhay Ranjan, Sanaullah Mudassir, Neetu Sinha, et al.

July 11, 2022
Research Article
Severity of Epilepsy and Response to Antiseizure Medications in Individuals With Multiple SclerosisAnalysis of a Real-World Dataset
Mauricio F. Villamar, Rani A. Sarkis, Page Pennell, et al.

May 18, 2022

Pages